¿Cuánto tiempo proporciona beneficio la estimulación  cerebral profunda a los pacientes? Publicado originalmente en la Revista Neuromodulation 2025;28: 472–483.  Traducción: Milagro Coto

Esin Bulut; P. Mitchell Johansen; Alya Elbualy; Cheyenne Kalman; Ryan Mayer; Nicholas Kato; Rodrigo Salmeron de Toledo Aguiar; Julie G. Pilitsis

doi:10.47924/neurotarget2026605

Authors

Esin Bulut Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
P. Mitchell Johansen Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL, USA
Alya Elbualy Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
Cheyenne Kalman Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
Ryan Mayer Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
Nicholas Kato Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
Rodrigo Salmeron de Toledo Aguiar Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA
Julie G. Pilitsis Department of Neurosurgery, University of Arizona, Tucson, AZ, USA

DOI:

https://doi.org/10.47924/neurotarget2026605

Keywords:

Deep brain stimulation, devices, dystonia, essential tremor, implantable pulse generator, longevity, Parkinson’s disease

Abstract

Introduction: One of the most common questions patients ask when they are contemplating deep brain stimulation (DBS) is how long it will last. To guide physicians in answering this query, we performed a scoping review to assess the current state of the literature and to identify the gaps that need to be addressed.
Materials and Methods: The authors performed a MEDLINE search inclusive of articles from January 1987 (advent of DBS literature) to June 2023 including human and modeling studies written in English. For longevity of therapy data, only studies with a mean follow-up of ≥three years were included. Using the Rayyan platform, two reviewers (JP and RM) performed a title screen. Of the 734 articles, 205 were selected by title screen and 109 from abstract review. Ultimately, a total of 122 articles were reviewed. The research
questions we explored were 1) how long can the different components of the DBS system maintain functionality? and 2) how long can DBS remain efficacious in treating Parkinson’s disease (PD), essential tremor (ET), dystonia, and other disorders?
Results: We showed that patients with PD, ET, and dystonia maintain a considerable long-term benefit in motor scores seven to ten years after implant, although the percentage improvement decreases over time. Stimulation off scores in PD and ET show worsening, consistent with disease progression. Battery life varies by the disease treated and the programming settings used.
There remains a paucity of literature after ten years, and the impact of new device technology has not been classified to date.
Conclusion: We reviewed existing data on DBS longevity. Overall, outcomes data after ten years of therapy are substantially limited in the current literature. We recommend that physicians who have data for patients with DBS exceeding this duration publish their results.

References

Khaleeq T, Hasegawa H, Samuel M, Ashkan K. Fixed-life or rechargeable battery for deep brain stimulation: which do patients prefer? Neuromodulation.2019;22:489–492.

Hornyak M, Rovit RL, Simon AS, Couldwell WT, Irving S. Cooper and the early surgical management of movement disorders. Video history. Neurosurg Focus. 2001;11:E6.

Fakhar K, Hastings E, Butson CR, Foote KD, Zeilman P, Okun MS. Management of deep brain stimulator battery failure: battery estimators, charge density, and importance of clinical symptoms. PLoS One. 2013;8:e58665.

Rosenow JM, Tarkin H, Zias E, Sorbera C, Mogilner A. Simultaneous use of bilateral subthalamic nucleus stimulators and an implantable cardiac defibrillator. Case report. J Neurosurg. 2003;99:167–169.

Hariz M, Hariz GM, Blomstedt P. Longevity of deep brain stimulation batteries; a global survey of neurosurgeons and neurologists. Mov Disord. 2021;36:1273–1274.

de Schlichting E, Coll G, Zaldivar-Jolissaint JF, et al. Pulse generator battery life in deep brain stimulation: out with the old… in with the less durable? Acta Neurochir (Wien). 2019;161:2043–2046.

Sette AL, Seigneuret E, Reymond F, et al. Battery longevity of neurostimulators in Parkinson disease: a historic cohort study. Brain Stimul. 2019;12:851–857.

Helmers AK, Birkenfeld F, Deuschl G, et al. Do adaptors shorten the battery life of nonrechargeable generators for deep brain stimulation? World Neurosurg.2019;127:e65–e68.

Israeli-Korn SD, Fay-Karmon T, Tessler S, et al. Decreasing battery life in subthalamic deep brain stimulation for Parkinson’s disease with repeated replacements: just a matter of energy delivered? Brain Stimul. 2019;12:845–850.

Lumsden DE, Kaminska M, Tustin K, et al. Battery life following pallidal deep brain stimulation (DBS) in children and young people with severe primary and secondary dystonia. Childs Nerv Syst. 2012;28:1091–1097.

Hitti FL, Vaughan KA, Ramayya AG, McShane BJ, Baltuch GH. Reduced long-term cost and increased patient satisfaction with rechargeable implantable pulse generators for deep brain stimulation. J Neurosurg. 2018;131:799–806.

Frizon LA, Hogue O, Wathen C, et al. Subsequent pulse generator replacement surgery does not increase the infection rate in patients with deep brain stimulator systems: a review of 1537 unique implants at a single center. Neuromodulation.2017;20:444–449.

Ondo WG, Meilak C, Vuong KD. Predictors of battery life for the Activa Soletra 7426 neurostimulator. Parkinsonism Relat Disord. 2007;13:240–242.

Ågren R, Bartek J, Johansson A, Blomstedt P, Fytagoridis A. Pulse width and implantable pulse generator longevity in pallidal deep brain stimulation for dystonia: a population-based comparative effectiveness study. Stereotact Funct Neurosurg. 2020;98:331–336.

Blahak C, Capelle HH, Baezner H, Kinfe TM, Hennerici MG, Krauss JK. Battery lifetime in pallidal deep brain stimulation for dystonia. Eur J Neurol. 2011;18:872–875.

van Riesen C, Tsironis G, Gruber D, et al. Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature. J Neural Transm (Vienna). 2016;123:621–630.

Ramirez-Zamora A, Kahn M, Campbell J, Delacruz P, Pilitsis JG. Interleaved programming of subthalamic deep brain stimulation to avoid adverse effects and preserve motor benefit in Parkinson’s disease. J Neurol. 2015;262:578–584. https://doi.org/10.1007/s00415-014-7605-3.

Kronenbuerger M, Fromm C, Block F, et al. On-demand deep brain stimulation for essential tremor: a report on four cases. Mov Disord. 2006;21:401–405.

Kuncel AM, Birdno MJ, Swan BD, Grill WM. Tremor reduction and modeled neural activity during cycling thalamic deep brain stimulation. Clin Neurophysiol. 2012;123:1044–1052.

Fytagoridis A, Heard T, Samuelsson J, et al. Surgical replacement of implantable pulse generators in deep brain stimulation: adverse events and risk factors in a multicenter cohort. Stereotact Funct Neurosurg. 2016;94:235–239.

Pepper J, Zrinzo L, Mirza B, Foltynie T, Limousin P, Hariz M. The risk of hardware infection in deep brain stimulation surgery is greater at impulse generator replacement than at the primary procedure. Stereotact Funct Neurosurg. 2013;91:56–65.

Pérez J, González V, Cif L, Cyprien F, Chan-Seng E, Coubes P. Rechargeable or nonrechargeable deep brain stimulation in dystonia: a cost analysis. Neuromodulation.2017;20:243–247.

Krause P, Völzmann S, Ewert S, Kupsch A, Schneider GH, Kühn AA. Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16 years. J Neurol. 2020;267:1622–1631.

Boviatsis EJ, Stavrinou LC, Themistocleous M, Kouyialis AT, Sakas DE. Surgical and hardware complications of deep brain stimulation. A seven-year experience and review of the literature. Acta Neurochir (Wien). 2010;152:2053–2062.

Volkmann J, Wolters A, Kupsch A, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012;11:1029–1038.

Bove F, Mulas D, Cavallieri F, et al. Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease. Neurology. 2021;97:e254–e262.

Falowski S, Ooi YC, Smith A, Verhargen Metman L, Bakay RAE. An evaluation of hardware and surgical complications with deep brain stimulation based on diagnosis and lead location. Stereotact Funct Neurosurg. 2012;90:173–180.

Allert N, Markou M, Miskiewicz AA, Nolden L, Karbe H. Electrode dysfunctions in patients with deep brain stimulation: a clinical retrospective study. Acta Neurochir (Wien). 2011;153:2343–2349, 1.

Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007;106:621–625.

Patel DM, Walker HC, Brooks R, Omar N, Ditty B, Guthrie BL. Adverse events associated with deep brain stimulation for movement disorders: analysis of 510 consecutive cases. Neurosurgery. 2015;11(suppl 2):190–199.

Yianni J, Nandi D, Shad A, Bain P, Gregory R, Aziz T. Increased risk of lead fracture and migration in dystonia compared with other movement disorders following deep brain stimulation. J Clin Neurosci. 2004;11:243–245.

Voges J, Waerzeggers Y, Maarouf M, et al. Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery–experiences from a single centre. J Neurol Neurosurg Psychiatry. 2006;77:868–872.

Bang Henriksen M, Johnsen EL, Sunde N, Vase A, Gjelstrup MC, Østergaard K.Surviving 10 years with deep brain stimulation for Parkinson’s disease–a followup of 79 patients. Eur J Neurol. 2016;23:53–61.

Teton ZE, Blatt D, Albakry A, et al. Natural history of neuromodulation devices and therapies: a patient-centered survival analysis. J Neurosurg. 2019;132:1385–1391.

Arocho-Quinones EV, Huang CC, Ward BD, Pahapill PA. Care bundle approach to minimizing infection rates after neurosurgical implants for neuromodulation: a single-surgeon experience. World Neurosurg. 2019;128:e87–e97.

Pilitsis JG, Metman LV, Toleikis JR, Hughes LE, Sani SB, Bakay RAE. Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor. J Neurosurg. 2008;109:640–646.

Sun DA, Yu H, Spooner J, et al. Postmortem analysis following 71 months of deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg. 2008;109:325–329.

Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 2003;349:1925–1934.

Schüpbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up. J Neurol Neurosurg Psychiatry. 2005;76:1640–1644.

Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson’s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord. 2008;14:114–119.

Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson’s disease: long-term observation. Mov Disord. 2009;24:557–563.

Gervais-Bernard H, Xie-Brustolin J, Mertens P, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: five year follow-up. J Neurol. 2009;256:225–233.

Lezcano E, Gómez-Esteban JC, Tijero B, et al. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease. J Neurol. 2016;263:895–905.

Yamamoto T, Uchiyama T, Higuchi Y, et al. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson’s disease after deep brain stimulation. J Neurol Sci. 2017;379:18–21.

Aviles-Olmos I, Kefalopoulou Z, Tripoliti E, et al. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease using an MRIguided and MRI-verified approach. J Neurol Neurosurg Psychiatry. 2014;85:1419–1425.

Bonenfant J, Drapier S, Houvenaghel JF, et al. Pallidal stimulation in Parkinson’s patients with contraindications to subthalamic target: a 3 years follow-up. Parkinsonism Relat Disord. 2017;34:20–25.

Kishore A, Rao R, Krishnan S, et al. Long-term stability of effects of subthalamic stimulation in Parkinson’s disease: Indian experience. Mov Disord. 2010;25:2438–2444.

Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain. 2010;133:2664–2676.

Jost ST, Sauerbier A, Visser-Vandewalle V, et al. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up. J Neurol Neurosurg Psychiatry. 2020;91:687–694.

Weaver FM, Stroupe KT, Smith B, et al. Survival in patients with Parkinson’s disease after deep brain stimulation or medical management. Mov Disord. 2017;32:1756–1763.

Schnalke N, Konitsioti A, Frank A, et al. Morbidity milestones demonstrate long disability-free survival in Parkinson’s disease patients with deep brain stimulation of the subthalamic nucleus. Mov Disord Clin Pract. 2023;10:569–578.

Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012;79:55–65.

Xu W, Li H, Zhang C, Sun B, Wu Y, Li D. Subthalamic nucleus stimulation in pediatric isolated dystonia: a 10-year follow-up. Can J Neurol Sci. 2020;47:328–335.

Pietzsch JB, Garner AM, Marks WJ. Cost-effectiveness of deep brain stimulation for advanced Parkinson’s disease in the United States. Neuromodulation. 2016;19:689–697.

Becerra JE, Zorro O, Ruiz-Gaviria R, et al. Economic analysis of deep brain stimulation in Parkinson disease: systematic review of the literature. World Neurosurg. 2016;93:44–49.

Fann JCY, Chang KC, Yen AMF, et al. Cost-effectiveness analysis of deep brain stimulation for Parkinson disease in Taiwan. World Neurosurg. 2020;138:e459–e468.

Dams J, Balzer-Geldsetzer M, Siebert U, et al. Cost-effectiveness of neurostimulation in Parkinson’s disease with early motor complications. Mov Disord. 2016;31:1183–1191.

Guo X, Feng C, Pu J, et al. Deep brain stimulation for advanced Parkinson disease in developing countries: a cost-effectiveness study from China. Neurosurgery. 2023;92:812–819.

Dams J, Siebert U, Bornschein B, et al. Cost-effectiveness of deep brain stimulation in patients with Parkinson’s disease. Mov Disord. 2013;28:763–771.

Deng H, Yue JK, Wang DD. Trends in safety and cost of deep brain stimulation for treatment of movement disorders in the United States: 2002–2014. Br J Neurosurg.2021;35:57–64.

Moon W, Kim SN, Park S, Paek SH, Kwon JS. The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder. Med (Baltimore). 2017;96:e7397.

Ostrem JL, San Luciano M, Dodenhoff KA, et al. Subthalamic nucleus deep brain stimulation in isolated dystonia: a 3-year follow-up study. Neurology. 2017;88:25–35.

Malatt C, Tagliati M. Long-term outcomes of deep brain stimulation for pediatric dystonia. Pediatr Neurosurg. 2022;57:225–237.

FitzGerald JJ, Rosendal F, de Pennington N, et al. Long-term outcome of deep brain stimulation in generalised dystonia: a series of 60 cases. J Neurol Neurosurg Psychiatry. 2014;85:1371–1376.

Zhang K, Bhatia S, Oh MY, Cohen D, Angle C, Whiting D. Long-term results of thalamic deep brain stimulation for essential tremor. J Neurosurg. 2010;112:1271–1276.

Rehncrona S, Johnels B, Widner H, Törnqvist AL, Hariz M, Sydow O. Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord. 2003;18:163–170.

Pahwa R, Lyons KE, Wilkinson SB, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006;104:506–512.

Tsuboi T, Jabarkheel Z, Zeilman PR, et al. Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor. Neurology. 2020;94:e1073–e1084.

Nazzaro JM, Pahwa R, Lyons KE. Long-term benefits in quality of life after unilateral thalamic deep brain stimulation for essential tremor. J Neurosurg. 2012;117:156–161.

Paschen S, Forstenpointner J, Becktepe J, et al. Long-term efficacy of deep brain stimulation for essential tremor: an observer-blinded study. Neurology. 2019;92:e1378–e1386.

Blomstedt P, Hariz GM, Hariz MI, Koskinen LO. Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up. Br J Neurosurg. 2007;21:504–509.

Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord. 2001;16:464–468.

Putzke JD, Wharen RE, Obwegeser AA, et al. Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis. Can J Neurol Sci. 2004;31:333–342.

Sydow O, Thobois S, Alesch F, Speelman JD. Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry. 2003;74:1387–1391.

Schuurman PR, Bosch DA, Merkus MP, Speelman JD. Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Mov Disord. 2008;23:1146–1153.

Mar-Barrutia L, Real E, Segalás C, Bertolín S, Menchón JM, Alonso P. Deep brain stimulation for obsessive-compulsive disorder: a systematic review of worldwide experience after 20 years. World J Psychiatry. 2021;11:659–680.

Luyten L, Hendrickx S, Raymaekers S, Gabriëls L, Nuttin B. Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder. Mol Psychiatry. 2016;21:1272–1280.

Choudhury TK, Davidson JE, Viswanathan A, Strutt AM. Deep brain stimulation ofthe anterior limb of the internal capsule for treatment of therapy-refractory obsessive compulsive disorder (OCD): a case study highlighting neurocognitive and psychiatric changes. Neurocase. 2017;23:138–145.

Fayad SM, Guzick AG, Reid AM, et al. Six-nine year follow-up of deep brain stimulation for obsessive-compulsive disorder. PLoS One. 2016;11:e0167875.

Graat I, Mocking R, Figee M, et al. Long-term outcome of deep brain stimulation of the ventral part of the anterior limb of the internal capsule in a cohort of 50 patients with treatment-refractory obsessive-compulsive disorder. Biol Psychiatry. 2021;90:714–720.

Gupta A, Khanna S, Jain R. Deep brain stimulation of ventral internal capsule for refractory obsessive-compulsive disorder. Indian J Psychiatry. 2019;61:532–536.

Greenberg BD, Gabriels LA, Malone DA, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010;15:64–79.

Holland MT, Trapp NT, McCormick LM, et al. Deep brain stimulation for obsessivecompulsive disorder: a long term naturalistic follow up study in a single institution. Front Psychiatry. 2020;11:55.

Lee DJ, Dallapiazza RF, De Vloo P, et al. Inferior thalamic peduncle deep brain stimulation for treatment-refractory obsessive-compulsive disorder: a phase 1 pilot trial. Brain Stimul. 2019;12:344–352.

Mallet L, Du Montcel ST, Clair AH, et al. Long-term effects of subthalamic stimulation in obsessive-compulsive disorder: follow-up of a randomized controlled trial. Brain Stimul. 2019;12:1080–1082.

Polosan M, Droux F, Kibleur A, et al. Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive-compulsive disorder. Transl Psychiatry. 2019;9:73.

Winter L, Saryyeva A, Schwabe K, et al. Long-term deep brain stimulation in treatment-resistant obsessive-compulsive disorder: outcome and quality of life at four to eight years follow-up. Neuromodulation. 2021;24:324–330.

Mar-Barrutia L, Ibarrondo O, Mar J, et al. Long-term comparative effectiveness of deep brain stimulation in severe obsessive-compulsive disorder. Brain Stimul. 2022;15:1128–1138.

Ackermans L, Duits A, Temel Y, et al. Long-term outcome of thalamic deep brain stimulation in two patients with Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010;81:1068–1072.

Kim SH, Lim SC, Kim J, Son BC, Lee KJ, Shon YM. Long-term follow-up of anterior thalamic deep brain stimulation in epilepsy: a 11-year, single center experience. Seizure. 2017;52:154–161.

Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant patial epilepsy. Neurology. 2015;84:1017–1025.

Kumar R, Lozano AM, Sime E, Lang AE. Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor. Neurology. 2003;61:1601–1604.

Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson’s disease. Ann Neurol. 2004;55:871–875.

Tarsy D, Scollins L, Corapi K, O’Herron S, Apetauerova D, Norregaard T. Progression of Parkinson’s disease following thalamic deep brain stimulation for tremor. Stereotact Funct Neurosurg. 2005;83:222–227.

Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry. 2008;79:694–699.

Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov Disord. 2010;25:578–586.

Zibetti M, Merola A, Rizzi L, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov Disord. 2011;26:2327–2334.

Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol. 2011;68:1550–1556.

Rodríguez-Oroz MC, Moro E, Krack P. Long-term outcomes of surgical therapies for Parkinson’s disease. Mov Disord. 2012;27:1718–1728.

Brüggemann N, Domingo A, Rasche D, et al. Association of pallidal neurostimulation and outcome predictors with X-linked dystonia parkinsonism. JAMA Neurol. 2019;76:211–216.

Georgiev D, Mencinger M, Rajnar R, et al. Long-term effect of bilateral STN-DBS on non-motor symptoms in Parkinson’s disease: a four-year observational, prospective study. Parkinsonism Relat Disord. 2021;89:13–16.

Jost ST, Ray Chaudhuri K, Ashkan K, et al. Subthalamic stimulation improves quality of sleep in Parkinson disease: a 36-month controlled study. J Parkinsons Dis. 2021;11:323–335.

Loher TJ, Capelle HH, Kaelin-Lang A, et al. Deep brain stimulation for dystonia: outcome at long-term follow-up. J Neurol. 2008;255:881–884.

Cersosimo MG, Raina GB, Piedimonte F, Antico J, Graff P, Micheli FE. Pallidal surgery for the treatment of primary generalized dystonia: long-term follow-up. Clin Neurol Neurosurg. 2008;110:145–150.

Mehrkens JH, Bötzel K, Steude U, et al. Long-term efficacy and safety of chronic globus pallidus internus stimulation in different types of primary dystonia. Stereotact Funct Neurosurg. 2009;87:8–17.

Vasques X, Cif L, Gonzalez V, Nicholson C, Coubes P. Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord. 2009;24:846–853.

Cif L, Vasques X, Gonzalez V, et al. Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: an open-label study. Mov Disord. 2010;25:289–299.

Tagliati M, Krack P, Volkmann J, et al. Long-term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord. 2011;26(suppl 1):S54–S62.

Cacciola F, Farah JO, Eldridge PR, Byrne P, Varma TK. Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients. Neurosurgery. 2010;67:957–963.

Petrossian MT, Paul LR, Multhaupt-Buell TJ, et al. Pallidal deep brain stimulation for dystonia: a case series. J Neurosurg Pediatr. 2013;12:582–587.

Tsuboi T, Jabarkheel Z, Foote KD, Okun MS, Wagle Shukla A. Importance of the initial response to GPi deep brain stimulation in dystonia: a nine year quality of life study. Parkinsonism Relat Disord. 2019;64:249–255.

Danielsson A, Carecchio M, Cif L, et al. Pallidal deep brain stimulation in DYT6 dystonia: clinical outcome and predictive factors for motor improvement. J Clin Med. 2019;8:2163.

Tsuboi T, Au KLK, Deeb W, et al. Motor outcomes and adverse effects of deep brain stimulation for dystonic tremor: a systematic review. Parkinsonism Relat Disord. 2020;76:32–41.

Tsuboi T, Cauraugh JH, Wong JK, Okun MS, Ramirez-Zamora A. Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis. J Neurol Neurosurg Psychiatry. 2020;91:938–944.

Cif L, Demailly D, Lin JP, et al. KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation. Brain. 2020;143:3242–3261.

Krause P, Kroneberg D, Gruber D, Koch K, Schneider GH, Kühn AA. Long-term effects of pallidal deep brain stimulation in tardive dystonia: a follow-up of 5–14 years. J Neurol. 2022;269:3563–3568.

Lin S, Shu Y, Zhang C, et al. Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia: a 3-year follow-up. Eur J Neurol. 2023;30:2629–2640.

Cury RG, Fraix V, Castrioto A, et al. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia. Neurology. 2017;89:1416–1423.